\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-focal\\ neurological\\ exam\\.\ \(0\)\
\-\ this\\ aneurysm\\ was\\ coiled\\ soon\\ after\\ discovery\\.\\ \\ interval\\ imaging\\ since\\ coiling\\ has\\ confirmed\\ resolution\\ for\\ the\\ past\\ three\\ years\\.\ \(0\)\
\-\ ct\\:\\ \\ there\\ is\\ a\\ berry\\ aneurysm\\ arising\\ from\\ the\\ supraclinoid\\ portion\\ of\\ the\\ left\\ internal\\ carotid\\ artery\\,\\ measuring\\ 16\\ mm\\ ap\\ x\\ 13\\.5\\ mm\\ cc\\ x12\\ mm\\ lat\\ with\\ a\\ 5\\-mm\\ neck\\.\\ the\\ aneurysm\\ projects\\ medially\\ and\\ inferiorly\\ from\\ its\\ origin\\ and\\ encroaches\\ on\\ the\\ optic\\ chiasm\\ and\\ pituitary\\ fossa\\.\\ the\\ pituitary\\ infundibulum\\ may\\ be\\ displaced\\ posteriorly\\.\\ \ \(0\)\
\-\ mr\\:\\ \\ the\\ ventricles\\ are\\ the\\ upper\\ limits\\ of\\ normal\\ in\\ size\\.\\ there\\ is\\ a\\ mixed\\ but\\ primarily\\ hypointense\\ signal\\ foci\\ in\\ the\\ parasellar\\ region\\ to\\ the\\ left\\ of\\ midline\\ superimposed\\ over\\ the\\ sella\\.\\ \\ on\\ t2wi\\ this\\ has\\ a\\ hypointense\\ signal\\ similar\\ to\\ the\\ signal\\ void\\ of\\ the\\ vesicle\\.\\ \\ mr\\ \\(t1w\\-gd\\)\\ shows\\ enhancement\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ mra\\ of\\ the\\ circle\\ of\\ willis\\ shows\\ a\\ flow\\ void\\ component\\ and\\ a\\ central\\ heterogeneous\\ hyperintense\\ signal\\ component\\.\ \(0\)\
\-\ berry\\ aneurysm\ \(8\)\
\-\ \\â\\€\\¢\\ congenital\\ berry\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ atherosclerotic\\ fusiform\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ mycotic\\ aneurysm\ \(1\)\
\-\ 68\\ y\\.o\\.\\ woman\\ with\\ 6\\ months\\ of\\ daily\\ frontal\\ headaches\\.\ \(1\)\
\-\ saccular\\ \\(berry\\)\\ aneurysms\\ are\\ rounded\\ outpouchings\\ that\\ arise\\ from\\ arterial\\ bifurcation\\ points\\.\\ \\ they\\ most\\ commonly\\ arise\\ secondary\\ to\\ abnormal\\ hemodynamic\\ shear\\ stresses\\,\\ and\\ are\\ not\\ congenital\\ as\\ previously\\ believed\\.\\ \\ berry\\ aneurysms\\ can\\ also\\ be\\ associated\\ with\\ trauma\\,\\ infection\\,\\ tumor\\,\\ drug\\ abuse\\,\\ avm\\,\\ and\\ avf\\.\\ \ \(0\)\
\-\ 15\\-20\\%\\ of\\ cases\\ are\\ multiple\\.\\ \\ they\\ are\\ found\\ in\\ the\\ cow\\ \\/\\ mca\\ bifurcation\\ 90\\%\\ of\\ the\\ time\\.\\ \\ most\\ berry\\ aneurysms\\ become\\ symptomatic\\ between\\ 40\\ and\\ 60\\ years\\ of\\ age\\,\\ commonly\\ presenting\\ with\\ subarachnoid\\ hemorrhage\\,\\ with\\ an\\ associated\\ high\\ mortality\\ and\\ morbidity\\ rate\\.\\ \\ the\\ risk\\ of\\ rupture\\ is\\ 1\\-2\\%\\ annually\\.\\ \\ there\\ is\\ a\\ 20\\-50\\%\\ rebleed\\ risk\\.\\ \\ larger\\ size\\ correlates\\ with\\ increased\\ rupture\\ risk\\,\\ but\\ there\\ is\\ no\\ critical\\ size\\ that\\ can\\ be\\ used\\ to\\ predict\\ risk\\ for\\ bleed\\.\\ \\ when\\ a\\ berry\\ aneurysm\\ is\\ discovered\\,\\ aneurysm\\ obliteration\\ is\\ necessary\\,\\ because\\ of\\ the\\ poor\\ prognosis\\ for\\ subarachnoid\\ hemorrhage\\.\ \(0\)\
\-\ ct\\:\\ \\ in\\ the\\ case\\ of\\ a\\ patent\\ aneurysm\\,\\ a\\ well\\-delineated\\ iso\\/hyperdense\\ lesion\\ that\\ exhibits\\ uniform\\ intense\\ enhancement\\ is\\ demonstrated\\.\\ \\ in\\ the\\ case\\ of\\ a\\ thrombosed\\ aneurysm\\,\\ the\\ residual\\ lumen\\ and\\ outer\\ rim\\ may\\ enhance\\ strongly\\.\\ \\ no\\ enhancement\\ is\\ seen\\ in\\ complete\\ thrombosis\\.\ \(0\)\
\-\ mr\\:\\ \\ appearance\\ can\\ be\\ highly\\ variable\\,\\ secondary\\ to\\ varied\\ flow\\ characteristics\\.\\ \\ patent\\ aneurysms\\ can\\ demonstrate\\ a\\ hyper\\ or\\ hypointense\\ signal\\ depending\\ on\\ flow\\.\\ \\ wall\\ enhancement\\ may\\ occur\\.\\ \\ thrombosed\\ aneurysms\\ demonstrate\\ flow\\ void\\ signal\\ surrounded\\ by\\ concentric\\ layers\\ of\\ clot\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ cebral\\ jr\\,\\ et\\ al\\.\\ characterization\\ of\\ cerebral\\ aneurysms\\ for\\ assessing\\ risk\\ of\\ rupture\\ by\\ using\\ patient\\-specific\\ computational\\ hemodynamics\\ models\\.\\ am\\ j\\ neuroradiol\\.\\ 2005\\;\\ 26\\(10\\)\\:2550\\-9\\.\ \(0\)\
\-\ foutrakis\\ gn\\,\\ yonas\\ h\\,\\ sclabassi\\ rj\\.\\ \\ saccular\\ aneurysm\\ formation\\ in\\ curved\\ and\\ bifurcating\\ arteries\\.\\ am\\ j\\ neuroradiol\\.\\ 1999\\;\\ 20\\(7\\)\\:1309\\-17\\.\ \(0\)\
\-\ osborn\\ ag\\.\\ diagnostic\\ neuroradiology\\.\\ \\ mosby\\,\\ st\\ louis\\,\\ 1994\\.\\ \\ pp\\ 248\\-281\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ berry\\:\\ 0\\.3924617116691181\ \(0\)\
\-\ aneurysm\\:\\ 0\\.3641866620587963\ \(0\)\
\-\ aneurysms\\:\\ 0\\.2558253316265402\ \(0\)\
\-\ the\\:\\ 0\\.16701736765979097\ \(0\)\
\-\ risk\\:\\ 0\\.14239806666298477\ \(0\)\
\-\ signal\\:\\ 0\\.13556778278126147\ \(0\)\
\-\ of\\:\\ 0\\.13260212733491022\ \(0\)\
\-\ void\\:\\ 0\\.13063885132671418\ \(0\)\
\-\ mm\\:\\ 0\\.11409877301849611\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.10646565328187947\ \(0\)\
\-\ flow\\:\\ 0\\.1061942233107644\ \(0\)\
\-\ hypointense\\:\\ 0\\.10522710354130752\ \(0\)\
\-\ is\\:\\ 0\\.09823960243171488\ \(0\)\
\-\ rupture\\:\\ 0\\.09667003962252875\ \(0\)\
\-\ saccular\\:\\ 0\\.09602353574040438\ \(0\)\
\-\ thrombosed\\:\\ 0\\.09462489669430256\ \(0\)\
\-\ enhancement\\:\\ 0\\.09176735392271475\ \(0\)\
\-\ bifurcation\\:\\ 0\\.0859739925346311\ \(0\)\
\-\ can\\:\\ 0\\.08366583838180501\ \(0\)\
\-\ and\\:\\ 0\\.08236263763359077\ \(0\)\
\-\ size\\:\\ 0\\.08096447281855373\ \(0\)\
\-\ mr\\:\\ 0\\.07737073074529506\ \(0\)\
\-\ 20\\:\\ 0\\.07714263174779012\ \(0\)\
\-\ are\\:\\ 0\\.07562237317711155\ \(0\)\
\-\ am\\:\\ 0\\.07525181096356585\ \(0\)\
\-\ pituitary\\:\\ 0\\.07353207971897487\ \(0\)\
\-\ arise\\:\\ 0\\.07295572061813868\ \(0\)\
\-\ patent\\:\\ 0\\.07226717114176294\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.07173976034790588\ \(0\)\
\-\ in\\:\\ 0\\.06940844727914211\ \(0\)\
\-\ component\\:\\ 0\\.06831424082825226\ \(0\)\
\-\ be\\:\\ 0\\.06467594284173858\ \(0\)\
\-\ x12\\:\\ 0\\.06374236241149246\ \(0\)\
\-\ rebleed\\:\\ 0\\.06374236241149246\ \(0\)\
\-\ cebral\\:\\ 0\\.06374236241149246\ \(0\)\
\-\ computational\\:\\ 0\\.06374236241149246\ \(0\)\
\-\ foutrakis\\:\\ 0\\.06374236241149246\ \(0\)\
\-\ yonas\\:\\ 0\\.06374236241149246\ \(0\)\
\-\ sclabassi\\:\\ 0\\.06374236241149246\ \(0\)\
\-\ there\\:\\ 0\\.0634382377607146\ \(0\)\
\-\ hemodynamics\\:\\ 0\\.06090923024255819\ \(0\)\
\-\ models\\:\\ 0\\.06090923024255819\ \(0\)\
\-\ gn\\:\\ 0\\.06090923024255819\ \(0\)\
\-\ bifurcating\\:\\ 0\\.06090923024255819\ \(0\)\
\-\ may\\:\\ 0\\.060174108907001034\ \(0\)\
\-\ commonly\\:\\ 0\\.05898670152724123\ \(0\)\
\-\ cow\\:\\ 0\\.05889909097880828\ \(0\)\
\-\ shear\\:\\ 0\\.057339905833461886\ \(0\)\
\-\ congenital\\:\\ 0\\.05727736427893099\ \(0\)\
\-\ they\\:\\ 0\\.0569592266651939\ \(0\)\
\-\ supraclinoid\\:\\ 0\\.054988851948769735\ \(0\)\
\-\ parasellar\\:\\ 0\\.05405581954612411\ \(0\)\
\-\ stresses\\:\\ 0\\.05405581954612411\ \(0\)\
\-\ curved\\:\\ 0\\.05405581954612411\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.05337248465123121\ \(0\)\
\-\ coiling\\:\\ 0\\.053232826640939736\ \(0\)\
\-\ encroaches\\:\\ 0\\.053232826640939736\ \(0\)\
\-\ vesicle\\:\\ 0\\.053232826640939736\ \(0\)\
\-\ annually\\:\\ 0\\.05249663440077771\ \(0\)\
\-\ predict\\:\\ 0\\.05249663440077771\ \(0\)\
\-\ varied\\:\\ 0\\.05249663440077771\ \(0\)\
\-\ osborn\\:\\ 0\\.05249663440077771\ \(0\)\
\-\ that\\:\\ 0\\.05189123689251104\ \(0\)\
\-\ willis\\:\\ 0\\.05122268737718984\ \(0\)\
\-\ outpouchings\\:\\ 0\\.05122268737718984\ \(0\)\
\-\ coiled\\:\\ 0\\.050663399868934\ \(0\)\
\-\ circle\\:\\ 0\\.050663399868934\ \(0\)\
\-\ rj\\:\\ 0\\.050663399868934\ \(0\)\
\-\ characterization\\:\\ 0\\.05014558051608556\ \(0\)\
\-\ neuroradiology\\:\\ 0\\.05014558051608556\ \(0\)\
\-\ to\\:\\ 0\\.049822689516860016\ \(0\)\
\-\ infundibulum\\:\\ 0\\.04966350223184343\ \(0\)\
\-\ avf\\:\\ 0\\.04966350223184343\ \(0\)\
\-\ ag\\:\\ 0\\.04966350223184343\ \(0\)\
\-\ hemodynamic\\:\\ 0\\.04921254811343993\ \(0\)\
\-\ years\\:\\ 0\\.04886541113238462\ \(0\)\
\-\ discovery\\:\\ 0\\.048788941832990776\ \(0\)\
\-\ for\\:\\ 0\\.04832317910698343\ \(0\)\
\-\ from\\:\\ 0\\.04749027717304043\ \(0\)\
\-\ projects\\:\\ 0\\.04731244834715128\ \(0\)\
\-\ assessing\\:\\ 0\\.04731244834715128\ \(0\)\
\-\ secondary\\:\\ 0\\.04725023443378459\ \(0\)\
\-\ louis\\:\\ 0\\.04698739607962206\ \(0\)\
\-\ with\\:\\ 0\\.04682871426155135\ \(0\)\
\-\ shows\\:\\ 0\\.046786941375307\ \(0\)\
\-\ exhibits\\:\\ 0\\.04667679544842876\ \(0\)\
\-\ concentric\\:\\ 0\\.04667679544842876\ \(0\)\
\-\ points\\:\\ 0\\.04637941594450566\ \(0\)\
\-\ obliteration\\:\\ 0\\.04609417782274713\ \(0\)\
\-\ jr\\:\\ 0\\.04582012843624982\ \(0\)\
\-\ st\\:\\ 0\\.04582012843624982\ \(0\)\
\-\ correlates\\:\\ 0\\.045556423039321295\ \(0\)\
\-\ superimposed\\:\\ 0\\.04505711326995262\ \(0\)\
\-\ mycotic\\:\\ 0\\.04505711326995262\ \(0\)\
\-\ pp\\:\\ 0\\.04505711326995262\ \(0\)\
\-\ soon\\:\\ 0\\.04415426391068779\ \(0\)\
\-\ critical\\:\\ 0\\.0439456704003066\ \(0\)\
\-\ layers\\:\\ 0\\.0439456704003066\ \(0\)\
\-\ hyper\\:\\ 0\\.043168496437518016\ \(0\)\
\-\ fusiform\\:\\ 0\\.04298699626731555\ \(0\)\
\-\ morbidity\\:\\ 0\\.04281009153540936\ \(0\)\
\-\ t2wi\\:\\ 0\\.04263755527109003\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.04263755527109003\ \(0\)\
\-\ believed\\:\\ 0\\.04263755527109003\ \(0\)\
\-\ chiasm\\:\\ 0\\.042304760771546955\ \(0\)\
\-\ associated\\:\\ 0\\.04201679983539022\ \(0\)\
\-\ lat\\:\\ 0\\.04183352401574458\ \(0\)\
\-\ uniform\\:\\ 0\\.04168325233854033\ \(0\)\
\-\ abuse\\:\\ 0\\.041536144511821485\ \(0\)\
\-\ clot\\:\\ 0\\.041536144511821485\ \(0\)\
\-\ most\\:\\ 0\\.04148710409591733\ \(0\)\
\-\ demonstrate\\:\\ 0\\.041442622167575195\ \(0\)\
\-\ mosby\\:\\ 0\\.041392070053362824\ \(0\)\
\-\ sella\\:\\ 0\\.04125090639006295\ \(0\)\
\-\ mca\\:\\ 0\\.04125090639006295\ \(0\)\
\-\ surrounded\\:\\ 0\\.040976857003565646\ \(0\)\
\-\ bleed\\:\\ 0\\.04084376033790334\ \(0\)\
\-\ medially\\:\\ 0\\.04071315160663712\ \(0\)\
\-\ strongly\\:\\ 0\\.04009439681452431\ \(0\)\
\-\ 1999\\:\\ 0\\.04009439681452431\ \(0\)\
\-\ case\\:\\ 0\\.040048918571764916\ \(0\)\
\-\ but\\:\\ 0\\.03942014624563462\ \(0\)\
\-\ mra\\:\\ 0\\.03941767185821925\ \(0\)\
\-\ mortality\\:\\ 0\\.03920591735991823\ \(0\)\
\-\ variable\\:\\ 0\\.038703012342887214\ \(0\)\
\-\ cc\\:\\ 0\\.03860663338482612\ \(0\)\
\-\ 68\\:\\ 0\\.038325225004833846\ \(0\)\
\-\ outer\\:\\ 0\\.038325225004833846\ \(0\)\
\-\ inferiorly\\:\\ 0\\.03823388561689933\ \(0\)\
\-\ primarily\\:\\ 0\\.03823388561689933\ \(0\)\
\-\ depending\\:\\ 0\\.03796682010272518\ \(0\)\
\-\ 2005\\:\\ 0\\.03788001943770285\ \(0\)\
\-\ daily\\:\\ 0\\.03779428383840586\ \(0\)\
\-\ intense\\:\\ 0\\.03762590548178293\ \(0\)\
\-\ characteristics\\:\\ 0\\.03654879862067865\ \(0\)\
\-\ has\\:\\ 0\\.036412370675202366\ \(0\)\
\-\ discovered\\:\\ 0\\.036338108376995124\ \(0\)\
\-\ rounded\\:\\ 0\\.03626926679868815\ \(0\)\
\-\ drug\\:\\ 0\\.03626926679868815\ \(0\)\
\-\ residual\\:\\ 0\\.03626926679868815\ \(0\)\
\-\ on\\:\\ 0\\.03611382157807428\ \(0\)\
\-\ interval\\:\\ 0\\.03606672033643653\ \(0\)\
\-\ larger\\:\\ 0\\.03567843357690706\ \(0\)\
\-\ enhance\\:\\ 0\\.03567843357690706\ \(0\)\
\-\ highly\\:\\ 0\\.03567843357690706\ \(0\)\
\-\ lumen\\:\\ 0\\.03549209283589957\ \(0\)\
\-\ become\\:\\ 0\\.035370570404584266\ \(0\)\
\-\ avm\\:\\ 0\\.03525112538184013\ \(0\)\
\-\ posteriorly\\:\\ 0\\.0351336879337909\ \(0\)\
\-\ prognosis\\:\\ 0\\.03507570118043584\ \(0\)\
\-\ ventricles\\:\\ 0\\.03501819168972073\ \(0\)\
\-\ origin\\:\\ 0\\.034310695028606536\ \(0\)\
\-\ optic\\:\\ 0\\.034310695028606536\ \(0\)\
\-\ by\\:\\ 0\\.03385243167357948\ \(0\)\
\-\ poor\\:\\ 0\\.03362124118128936\ \(0\)\
\-\ carotid\\:\\ 0\\.0335745027884445\ \(0\)\
\-\ necessary\\:\\ 0\\.033345388371455786\ \(0\)\
\-\ displaced\\:\\ 0\\.033300453401947205\ \(0\)\
\-\ mixed\\:\\ 0\\.03299374870822735\ \(0\)\
\-\ arterial\\:\\ 0\\.03282434977704954\ \(0\)\
\-\ using\\:\\ 0\\.03278263404909875\ \(0\)\
\-\ neurological\\:\\ 0\\.03274116589369137\ \(0\)\
\-\ foci\\:\\ 0\\.032577711336636304\ \(0\)\
\-\ thrombosis\\:\\ 0\\.032497395927340224\ \(0\)\
\-\ 26\\:\\ 0\\.03237862767961502\ \(0\)\
\-\ resolution\\:\\ 0\\.03233948268268154\ \(0\)\
\-\ previously\\:\\ 0\\.031996709473171986\ \(0\)\
\-\ 90\\:\\ 0\\.03184960164645313\ \(0\)\
\-\ references\\:\\ 0\\.03177719308472212\ \(0\)\
\-\ rim\\:\\ 0\\.03174126825660079\ \(0\)\
\-\ hyperintense\\:\\ 0\\.03170552718799447\ \(0\)\
\-\ arising\\:\\ 0\\.03166996800856513\ \(0\)\
\-\ al\\:\\ 0\\.03166996800856513\ \(0\)\
\-\ arteries\\:\\ 0\\.031634588876385164\ \(0\)\
\-\ formation\\:\\ 0\\.031599387977364946\ \(0\)\
\-\ limits\\:\\ 0\\.03149483694431095\ \(0\)\
\-\ fossa\\:\\ 0\\.031290314138197294\ \(0\)\
\-\ presenting\\:\\ 0\\.03122344890375236\ \(0\)\
\-\ et\\:\\ 0\\.03122344890375236\ \(0\)\
\-\ 16\\:\\ 0\\.031059032760832203\ \(0\)\
\-\ measuring\\:\\ 0\\.03083516214422289\ \(0\)\
\-\ symptomatic\\:\\ 0\\.030648821403215395\ \(0\)\
\-\ similar\\:\\ 0\\.030378309027007545\ \(0\)\
\-\ diagnostic\\:\\ 0\\.030378309027007545\ \(0\)\
\-\ ct\\:\\ 0\\.030348983537326395\ \(0\)\
\-\ rate\\:\\ 0\\.0302036158360844\ \(0\)\
\-\ midline\\:\\ 0\\.029977284674929175\ \(0\)\
\-\ used\\:\\ 0\\.029839462382703234\ \(0\)\
\-\ 60\\:\\ 0\\.029812221164270795\ \(0\)\
\-\ headaches\\:\\ 0\\.029731128992850898\ \(0\)\
\-\ its\\:\\ 0\\.029493350763620616\ \(0\)\
\-\ confirmed\\:\\ 0\\.02939021437190865\ \(0\)\
\-\ 40\\:\\ 0\\.029313848981441955\ \(0\)\
\-\ occur\\:\\ 0\\.029313848981441955\ \(0\)\
\-\ since\\:\\ 0\\.0288723950190602\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.028848668803809548\ \(0\)\
\-\ ap\\:\\ 0\\.02861573511169015\ \(0\)\
\-\ portion\\:\\ 0\\.02850211693877161\ \(0\)\
\-\ complete\\:\\ 0\\.02793936261641458\ \(0\)\
\-\ because\\:\\ 0\\.027856670956907668\ \(0\)\
\-\ cerebral\\:\\ 0\\.027614310348885358\ \(0\)\
\-\ this\\:\\ 0\\.02739217258769081\ \(0\)\
\-\ left\\:\\ 0\\.027193183305953602\ \(0\)\
\-\ internal\\:\\ 0\\.0268622557553103\ \(0\)\
\-\ cases\\:\\ 0\\.02680898461791124\ \(0\)\
\-\ three\\:\\ 0\\.026756116544680773\ \(0\)\
\-\ central\\:\\ 0\\.026617059941861542\ \(0\)\
\-\ past\\:\\ 0\\.025944837579670914\ \(0\)\
\-\ no\\:\\ 0\\.025923038421919186\ \(0\)\
\-\ between\\:\\ 0\\.025898099186826055\ \(0\)\
\-\ found\\:\\ 0\\.02579024358176502\ \(0\)\
\-\ frontal\\:\\ 0\\.025653974315777678\ \(0\)\
\-\ age\\:\\ 0\\.025023538787973393\ \(0\)\
\-\ artery\\:\\ 0\\.024754760894504405\ \(0\)\
\-\ demonstrated\\:\\ 0\\.024495940058192552\ \(0\)\
\-\ neck\\:\\ 0\\.024382526796304323\ \(0\)\
\-\ wall\\:\\ 0\\.024246364825184816\ \(0\)\
\-\ infection\\:\\ 0\\.024076819086773595\ \(0\)\
\-\ when\\:\\ 0\\.024076819086773595\ \(0\)\
\-\ appearance\\:\\ 0\\.024029123586376027\ \(0\)\
\-\ abnormal\\:\\ 0\\.023946431926869113\ \(0\)\
\-\ region\\:\\ 0\\.023841532086629383\ \(0\)\
\-\ time\\:\\ 0\\.023625117216892293\ \(0\)\
\-\ 10\\:\\ 0\\.023307205842858995\ \(0\)\
\-\ months\\:\\ 0\\.023200851222173878\ \(0\)\
\-\ trauma\\:\\ 0\\.023148274874204743\ \(0\)\
\-\ high\\:\\ 0\\.02265293981731319\ \(0\)\
\-\ over\\:\\ 0\\.022163058781084783\ \(0\)\
\-\ increased\\:\\ 0\\.021553562455514867\ \(0\)\
\-\ upper\\:\\ 0\\.021299746296755594\ \(0\)\
\-\ imaging\\:\\ 0\\.020946972149080843\ \(0\)\
\-\ tumor\\:\\ 0\\.02084828965300558\ \(0\)\
\-\ woman\\:\\ 0\\.02075841878479603\ \(0\)\
\-\ exam\\:\\ 0\\.02006477111121904\ \(0\)\
\-\ multiple\\:\\ 0\\.01949564260879548\ \(0\)\
\-\ after\\:\\ 0\\.019335994666094716\ \(0\)\
\-\ lesion\\:\\ 0\\.01910903469686602\ \(0\)\
\-\ seen\\:\\ 0\\.018765042496725136\ \(0\)\
\-\ also\\:\\ 0\\.018748279521046123\ \(0\)\
\-\ normal\\:\\ 0\\.01627394391161125\ \(0\)\
\-\ as\\:\\ 0\\.01601255989798567\ \(0\)\
\-\ not\\:\\ 0\\.015735173765453733\ \(0\)\
\-\ an\\:\\ 0\\.015241743141301585\ \(0\)\
\-\ was\\:\\ 0\\.013891069596451573\ \(0\)\
\-\ or\\:\\ 0\\.013866050165264697\ \(0\)\
